Promedior logo

Promedior

Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source, enhancing precision and minimizing systemic risks

est. 2006

VS
Rubedo Life Sciences logo

Rubedo Life Sciences

Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging

32 employees · est. 2018 · Sunnyvale, United States

Promedior is the older company (2006 vs 2018).

Side-by-Side Comparison

Promedior Rubedo Life Sciences
Founded
2006 older 2018
Headquarters
Not tracked yet Sunnyvale, United States
Employees
Not tracked yet 32
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Series Unknown Series A
Total Funding
$63.00M $53.45M
Funding Rounds
7 7
Services
Not tracked yet Drug discovery and development, Clinical trials for anti-aging and chronic disease therapies, Research in biology of aging
Target Customers
Not tracked yet Patients with chronic diseases, Individuals seeking longevity and anti-aging solutions, Healthcare providers, Scientific researchers
Taxonomy
Biopharmaceutical, Drug Discovery, Therapeutics, Fibrotic Diseases, Inflammatory Diseases, Clinical-stage, Monocyte-derived Cell Populations, Immunotherapy, Tissue Healing, Precision Medicine, Autoimmune Conditions, Eye Diseases, Lung Diseases, Kidney Diseases, Novel Therapeutics Biopharmaceutical, Drug Discovery, Senescent Cells, Chronic Diseases, Innovative Therapies, Small Molecules, Pulmonary Diseases, Dermatological Diseases, Oncological Diseases, Neurodegenerative Diseases, Fibrotic Diseases, Biotech Innovators, Sunnyvale, California, Drug Development
Website
promedior.com rubedolife.com
Promedior logo

About Promedior

Promedior is a biopharmaceutical startup founded in 2006, focused on developing innovative treatments for inflammatory and fibrotic diseases. The company's unique drug discovery platform targets monocyte-derived cell populations critical in fibrotic, inflammatory, and autoimmune conditions, directly...

Rubedo Life Sciences logo

About Rubedo Life Sciences

Rubedo Life Sciences, founded in 2018, is a promising player in the biotechnology, healthcare, and life sciences sectors. Headquartered in Sunnyvale, CA, this biopharmaceutical company is heralding a new era in age-related disease treatment with its pioneering approach. The company is known for its...

We will tell you when either one moves

BounceWatch watches Promedior and Rubedo Life Sciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Promedior and Rubedo Life Sciences — by email.

Frequently Asked Questions

Promedior — Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source, enhancing precision and minimizing systemic risks. Rubedo Life Sciences — Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Promedior has raised $63.00M while Rubedo Life Sciences has raised $53.45M.
Promedior and Rubedo Life Sciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Promedior with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Promedior on 12 Sep 2024, and Rubedo Life Sciences on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy